Sanofi could be months away from wider US approval for Tzield, its first-in-class drug for delaying the progression of type 1 ...

BENGALURU: Across Bengaluru and several other cities, ophthalmologists reported that there is a steady rise in diabetic ...

Qatar has set an ambitious target to achieve diabetes control by 2030, launching an aggressive prevention campaign as health ...

Dad John Story said the introduction of "Lyla's Law" – routine testing for those showing symptoms – would be a "lasting ...

The Department of Health (DOH) said Monday that among their priorities to address this year is the stunting among children.

For parents of kids with Type 1 diabetes (T1D) — an autoimmune condition in which the pancreas stops producing insulin — that ...

Gestational diabetes rose every single year in the U.S. from 2016 through 2024, according to a new Northwestern Medicine ...

Investing.com -- Sanofi announced Monday that the U.S. Food and Drug Administration has accepted a priority review for its Tzield type-1 diabetes drug, potentially expanding its use to children as ...

Semaglutide, the active ingredient in medications like Ozempic and Wegovy, shows promise as a treatment for alcohol addiction ...

Find High Bp In Children Latest News, Videos & Pictures on High Bp In Children and see latest updates, news, information from NDTV.COM. Explore more on High Bp In Children.

The sBLA is supported by 1-year interim data from the ongoing phase 4 PETITE-T1D study, which included 23 children less than 8 years of age with stage 2 T1D.

The company said the regulator accepted a priority review to potentially expand the current age range for its Tzield type-1 diabetes drug to include children as young as one year old.